Table 1 Clinical and demographic characteristics of patients
From: Disruption of orbitofrontal-hypothalamic projections in a murine ALS model and in human patients
| n (m/f) |
Age in years (range) | ALS-FRS-R |
Disease duration in months | Genotype | |
|---|---|---|---|---|---|
| Controls | 43 (24/19) | 56 ± 9 (44–76) | – | – | – |
| ALS |
72 (42/30) |
58 ± 13 (20–85) |
40 ± 6 (23–48) | 19 ± 15 (1–60) |
8 C9orf72, 3 SOD1, 1 Fus |